These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Modulation of aberrant splicing in human RNA diseases by chemical compounds. Kataoka N Hum Genet; 2017 Sep; 136(9):1237-1245. PubMed ID: 28364159 [TBL] [Abstract][Full Text] [Related]
4. Exploring the Diverse Functional and Regulatory Consequences of Alternative Splicing in Development and Disease. Titus MB; Chang AW; Olesnicky EC Front Genet; 2021; 12():775395. PubMed ID: 34899861 [TBL] [Abstract][Full Text] [Related]
5. The High Level of Aberrant Splicing of ISCU in Slow-Twitch Muscle May Involve the Splicing Factor SRSF3. Rawcliffe DF; Österman L; Lindsten H; Holmberg M PLoS One; 2016; 11(10):e0165453. PubMed ID: 27783661 [TBL] [Abstract][Full Text] [Related]
6. Contributions of alternative splicing to muscle type development and function. Nikonova E; Kao SY; Spletter ML Semin Cell Dev Biol; 2020 Aug; 104():65-80. PubMed ID: 32070639 [TBL] [Abstract][Full Text] [Related]
7. [The role of RNA splicing in the pathogenesis of spinal muscular atrophy and development of its therapeutics]. Sahashi K; Sobue G Brain Nerve; 2014 Dec; 66(12):1471-80. PubMed ID: 25475034 [TBL] [Abstract][Full Text] [Related]
8. [RNA pathologies in neurological disorders]. Ohno K Rinsho Shinkeigaku; 2007 Nov; 47(11):801-4. PubMed ID: 18210802 [TBL] [Abstract][Full Text] [Related]
9. Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions. Singh NN; Lee BM; Singh RN Ann N Y Acad Sci; 2015 Apr; 1341():176-87. PubMed ID: 25727246 [TBL] [Abstract][Full Text] [Related]
10. Antisense-mediated exon skipping: taking advantage of a trick from Mother Nature to treat rare genetic diseases. Veltrop M; Aartsma-Rus A Exp Cell Res; 2014 Jul; 325(1):50-5. PubMed ID: 24486759 [TBL] [Abstract][Full Text] [Related]
12. Minor splicing pathway is not minor any more: implications for the pathogenesis of motor neuron diseases. Onodera O; Ishihara T; Shiga A; Ariizumi Y; Yokoseki A; Nishizawa M Neuropathology; 2014 Feb; 34(1):99-107. PubMed ID: 24112438 [TBL] [Abstract][Full Text] [Related]
13. [Biochemistry of mitochondrial encephalomyopathy]. Ozawa T; Tanaka M No To Shinkei; 1990 Aug; 42(8):707-17. PubMed ID: 2223265 [No Abstract] [Full Text] [Related]
14. Muscle-specific expression of the RNA-binding protein Staufen1 induces progressive skeletal muscle atrophy via regulation of phosphatase tensin homolog. Crawford Parks TE; Ravel-Chapuis A; Bondy-Chorney E; Renaud JM; Côté J; Jasmin BJ Hum Mol Genet; 2017 May; 26(10):1821-1838. PubMed ID: 28369467 [TBL] [Abstract][Full Text] [Related]
15. Deciphering targeting rules of splicing modulator compounds: case of TG003. Sakuma M; Iida K; Hagiwara M BMC Mol Biol; 2015 Sep; 16():16. PubMed ID: 26400733 [TBL] [Abstract][Full Text] [Related]
16. Encephalopathy, petechiae, and acrocyanosis with ethylmalonic aciduria associated with muscle cytochrome c oxidase deficiency. García-Silva MT; Campos Y; Ribes A; Briones P; Cabello A; Santos Borbujo J; Arenas J; Garavaglia B J Pediatr; 1994 Nov; 125(5 Pt 1):843-4. PubMed ID: 7965445 [No Abstract] [Full Text] [Related]